NCT03662659 2025-02-05
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
Bristol-Myers Squibb
Phase 2 Completed
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Hoffmann-La Roche
AstraZeneca
Hoffmann-La Roche